FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology, and can be applied for treatment of "dry" form of age macular degeneration. Suspension of autologic cultured mesenchymal stem cells of own marrow in amount 1-2 × 107 cells in 0.1 ml of physiological solution is introduced to patient intravitreally.
EFFECT: method ensures improvement or stabilisation of visual functions in patients with "dry" form of age macular degeneration.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING "DRY" FORM OF AGE-SPECIFIC MACULAR DEGENERATION | 2011 |
|
RU2470619C1 |
| METHOD OF TREATING "DRY" FORM OF AGE-RELATED MACULAR DEGENERATION | 2011 |
|
RU2471458C1 |
| METHOD TO TREAT "DRY" FORM OF AGE MACULAR DEGENERATION | 2007 |
|
RU2333737C1 |
| METHOD OF INCREASING EFFECIENCY OF PHOTODYNAMIC THERAPY OF CHOROIDAL NEOVASCULARISATION | 2008 |
|
RU2375023C1 |
| METHOD OF TREATING "DRY" FORM OF AGE-RELATED MACULAR DEGENERATION | 2012 |
|
RU2485922C1 |
| METHOD OF TREATING OPTIC NERVE ATROPHY OF VARIOUS ETIOLOGY | 2008 |
|
RU2375022C1 |
| METHOD OF TREATING OPTIC NERVE ATROPHY OF VARIOUS ETIOLOGY | 2008 |
|
RU2375019C1 |
| THREE-COMPONENT COMPLEX FOR CELL THERAPY IN OPHTHALMOLOGY | 2012 |
|
RU2495650C1 |
| METHOD OF TREATING OPTIC NERVE ATROPHY OF DIFFERENT ETIOLOGY | 2011 |
|
RU2482823C2 |
| METHOD OF SUBRETINAL TRANSPLANTATION OF RETINAL PIGMENT EPITHELIUM (RPE) CELLS DIFFERENTIATED FROM HUMAN INDUCED PLURIPOTENT STEM CELLS, WITH ATROPHY OF RETINAL PIGMENT EPITHELIUM IN EXPERIMENT | 2019 |
|
RU2729937C1 |
